Cannabis Stocks That Could Uptrend
HENDERSON, NV / ACCESSWIRE / November 27, 2018 / The cannabis sector certainly took a hit in recent weeks, however, not all cannabis stocks have been affected. Here's a couple that still warrant your attention.
Today we are highlighting: Real Brands, Inc. (RLBD), CV Sciences, Inc. (CVSI), Puration Inc. (PURA), INSYS Therapeutics, Inc. (INSY), and Aurora Cannabis, Inc. (ACB).
Earlier this week, Coca-Cola CEO, James Quincey, spoke with Jim Cramer about the company's plans in the Cannabis market. He noted the company is in no rush to jump in the space, because the "science is out". This is great news for smaller cannabis companies developing CBD beverages, they have time to gain a piece of the market and make themselves an attractive candidate to companies like Coca-Cola when they decide to enter the space.
Take, Real Brands, Inc. (RLBD) (Market Cap: $18.2M Share Price: $0.14) the company is developing a CBD beverage brand: Omega Hemp. They recently stated that they are in the final stages of scheduling their first production run which they will confirm in the next 60 days. RLBD has strong management with a solid background in branding and the beverage industry; and plans to expand their holdings focusing on at least three CBD Categories: smokables, edibles and topical balms and lotions.
CV Sciences, Inc. (CVSI) (Market Cap: $433M Share Price: $4.53). The company reported Q3/18 earnings November 7, surpassing expectations. Top line year to year sales growth was over 143%. CVSI operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and a consumer product division focused on manufacturing, marketing and selling plant-based CBD products (PlusCBD Oil™) to a range of market sectors.
Another CBD beverage play like RLBD, Puration, Inc. (PURA). (Market Cap: $5.49M Share Price: $0.10) has been climbing. Puration, Inc. is a Texas-based, CBD-infused beverage provider. The Company's flagship product, EVERx, which was introduced in 2017, targets the sports nutrition market.
INSYS Therapeutics, Inc. (INSY)
Market Cap: $567.97M Share Price: $7.65
NSYS Therapeutics, Inc. (INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, recently reported financial results for its third quarter ended Sept. 30, 2018. The company achieved net revenue of $18.3 million in the third quarter of 2018.
Aurora Cannabis, Inc. (ACB)
Market Cap: $6.30B Share Price: $6.70
Aurora Cannabis Inc. (ACB), just announced the official opening of its latest high-tech cannabis production facility in Lachute, Quebec; the company is calling it "Eau."
At 48,000 square feet, with 11 purpose-built grow rooms, Aurora Eau will produce up to 4,500 kg of high-quality cannabis per year, all in a facility with some of the lowest electricity costs in North America. It is designed to grow niche varieties of cannabis for the premium medical and adult consumer use markets in Quebec, Canada and around the world. Eau becomes Aurora's second production facility in Quebec , the first being Aurora Vie, a 40,000 square foot indoor grow facility in Pointe Claire, Quebec.
Legal Disclaimer:
This article was written by Regal Consulting, LLC ("Regal Consulting"). Regal Consulting has agreed to a three month term consulting agreement with RLBD dated 8/31/18. The agreement calls for $100,000 note issued to Regal Consulting, and 2,500,000 restricted 144 shares of RLBD for three months of service. Regal has elected to convert $73,000 of principal of the $100,000 note into 2,761,872 Restricted 144 shares of RLBD. All payments were made directly by Real Brands, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspecultors.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. RLBD was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.
http://www.regalconsultingllc.com/full legal disclaimer/
Microspeculators.com Full Legal Disclaimer Click Here.
Contact Information:
Company Name: Microcap Speculators
Contact Person: Media Manager
Email: info@microcapspecualtors.com
Phone: 1-702-720-6310
Country: United States
Website: http://microcapspeculators.com/
SOURCE: ACR Communication, LLC
